SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2024 quarter moved down -65.28% to Rs. 165.60 millions as compared to Rs. 476.90 millions during the year ago period.The Net Loss for the quarter ended March 2024 is Rs. -1066.90 millions as compared to Net Loss of Rs. -819.90 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 further decreased to -1031.20% as compared to -788.40% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 165.60 476.90 -65.28 755.50 2387.80 -68.36 755.50 2387.80 -68.36
Other Income 44.00 107.30 -58.99 294.70 108.80 170.86 294.70 108.80 170.86
PBIDT -1031.20 -788.40 30.80 -3743.20 -2031.80 84.23 -3743.20 -2031.80 84.23
Interest 8.80 2.10 319.05 16.60 76.30 -78.24 16.60 76.30 -78.24
PBDT -1040.00 -790.50 31.56 -3759.80 -2108.10 78.35 -3759.80 -2108.10 78.35
Depreciation 26.90 29.40 -8.50 121.30 117.70 3.06 121.30 117.70 3.06
PBT -1066.90 -819.90 30.13 -3881.10 -2225.80 74.37 -3881.10 -2225.80 74.37
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1066.90 -819.90 30.13 -3881.10 -2225.80 74.37 -3881.10 -2225.80 74.37
Equity 324.50 324.50 0.00 324.50 324.50 0.00 324.50 324.50 0.00
PBIDTM(%) -622.71 -165.32 276.67 -495.46 -85.09 482.27 -495.46 -85.09 482.27

Sun Pharma Adv. Res Share Price

147.90 -4.25 (-2.79%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×